Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)
AstraZeneca
AstraZeneca
AstraZeneca
AstraZeneca
AstraZeneca
Amgen
Georgetown University
Akeso
National Health Research Institutes, Taiwan
AbbVie
University of Nebraska
Merck Sharp & Dohme LLC
Eli Lilly and Company
3D Medicines
Instituto do Cancer do Estado de São Paulo
Fujifilm Pharmaceuticals U.S.A., Inc.
Oslo University Hospital
Carisma Therapeutics Inc
Peking University
Seoul National University Hospital